
-
Architects: estudioSIC
- Area: 8380 m²
- Year: 2011
-
Photographs:Esaú Acosta. estudiosic
Text description provided by the architects. The biopharmaceutical facilities, first antibody monoclonal manufacturing plant built in Spain, is the expression of the complex inner manufacturing processes of the product: a technological, efficient and sustainable solution. The new biopharma facilities Genhelix is located in a place marked by the passing of the High Speed Train Madrid-Asturias, being this condition the generator of the place: a dynamic and orientated “genius loci”. The building incorporates this status, taking advantage of the maximum visibility in both ways and responding to the different mobility levels that occur in the science park: HST, private vehicle and pedestrian.




















